Self‐Assembly of Stimuli‐Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo
Advanced Materials · 2026
DOI: 10.1002/adma.73468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Renwei Jing und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Depa…. Hauptthemen laut MEDLINE: Lysosomes, Carcinoma, Hepatocellular, Peptides, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Tianjin "Belt and Road" Joint Laboratory Project, Science and Technology Planning Projects of Tianjin Municipality.
Abstract (Originalsprache)
Lysosome sequestration or drug‐triggered autophagic flux curtails antitumor drug potency in hepatocellular carcinoma (HCC) and can potentially be reversed with tumor cell‐specific lysosomal disruption. Here, we demonstrate that a chimeric peptide (RS‐FS), consisting of HCC‐targeting RS and nanostructure‐forming motifs (FS), self‐assembles into nanospheres at neutral pH and transforms into nanofibers under acidic and reductive conditions. These nanofibers specifically localize to tumors and disrupt tumor cell lysosomes, thus enhancing doxorubicin's activity in human HCC cells in vitro and orthotopic HCC mice in vivo after RS‐FS‐doxorubicin treatment. Importantly, intravenous RS‐FS potentiated oral Lenvatinib's antitumor activity up to 61‐fold, and eradicated tumors in orthotopic HCC mice via HCC cell‐specific lysosome disruption. Potent antitumor effects were also achieved with intravenous RS‐FS and oral Epimedium brevicornu Maxim. ‐derived extracellular vesicles in orthotopic HCC mice, with markedly reduced tumor growth and increased cytotoxic T infiltration, in which RS‐FS‐mediated lysosome disruption promoted drug release and autophagic flux blockade. Our study demonstrates that RS‐FS self‐assembles into nanospheres or nanofibers in response to stimuli and enables tumor cell‐specific lysosome disruption, resulting in enhanced drug release, autophagic flux blockade, and antitumor activities of diverse therapeutics in HCC mice, and thus provides a generalizable peptide adjuvant for sensitizing HCC‐targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Cell Biology, Division of Medical Technology, Tianjin Medica…
- Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (ASTAR), Singapore, Republic of Singapore.
Förderung
- National Key R&D Program of China
- Tianjin "Belt and Road" Joint Laboratory Project
- Science and Technology Planning Projects of Tianjin Municipality
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Jing, R., Kong, X., Zhang, J., Li, J., He, X., Yang, Z., Wang, Y., Zhang, L., Wang, Q., Seow, Y., & Yin, H. (2026). Self‐Assembly of Stimuli‐Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo. Advanced Materials. https://doi.org/10.1002/adma.73468
Vancouver
Jing R, Kong X, Zhang J, Li J, He X, Yang Z, et al. Self‐Assembly of Stimuli‐Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo. Advanced Materials. 2026. doi:10.1002/adma.73468
BibTeX
@article{Jing2026,
author = {Jing, Renwei and Kong, Xiaorong and Zhang, Jin and Li, Jiaxue and He, Xingjie and Yang, Zhongqiu and Wang, Yi and Zhang, Leijie and Wang, Qian and Seow, Yiqi and Yin, HaiFang},
title = {Self‐Assembly of Stimuli‐Responsive Peptide Enhances Therapeutics by Specifically Disrupting Hepatocellular Carcinoma Lysosomes In Vivo},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.73468}
}
EUVIMED